European equities traded in the US as American depositary receipts were tracking lower late Wednesday morning, falling 0.84% to 1,466.92 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company DBV Technologies (DBVT) and medical device maker EDAP TMS (EDAP), which rose 4.4% and 2.9% respectively. They were followed by internet browser company Opera (OPRA) and oil and gas company TotalEnergies (TTE), which were up 1.1% and 0.9%.
The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and pharmaceutical company Ascendis Pharma (ASND), which lost 6.5% and 4.4% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and Spanish lender Banco Bilbao Vizcaya Argentaria (BBVA), which dropped 4.2% and 3.5%.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Amarin (AMRN) and Mereo BioPharma Group (MREO), which increased 4% and 1.8% respectively. They were followed by insurance firm Prudential (PUK) and lender HSBC (HSBC), which edged 0.6% and 0.4% higher respectively.
The decliners from the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and biotech firm Autolus Therapeutics (AUTL), which lost 3.3% and 3.1% respectively. They were followed by communications company WPP (WPP) and biotech firm Trinity Biotech (TRIB), which shed 3% and 2.6% respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。